SCHEMBL1209508

SCHEMBL1209508

Cc1n[nH]cc1C(C)NC(=O)OC1CCc2c(sc(NC(=O)CC(C)c3ccccn3)c2C#N)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.41
ALDH1A1 P00352 8/20 0.40
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
POLB P06746 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TP53 P04637 1/20 0.40
MCL1 Q07820 1/20 0.40
RAB9A P51151 7/20 0.39
NPC1 O15118 6/20 0.39
HTT P42858 3/20 0.39
KDM4E B2RXH2 2/20 0.39
HSD17B10 Q99714 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
RECQL P46063 1/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
GCGR P47871 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1209254 0.91 MAPT (0.43) MAPTALDH1A1KMT2AMEN1POLB
SCHEMBL1209185 0.90 ALDH1A1 (0.42) MAPTALDH1A1KMT2AMEN1POLB
SCHEMBL1207642 0.88 MAPT (0.41) MAPTALDH1A1KMT2AMEN1POLB
SCHEMBL1208708 0.88 MAPT (0.39) MAPTALDH1A1KMT2AMEN1POLB
SCHEMBL1209726 0.87 RAB9A (0.41) MAPTALDH1A1KMT2AMEN1POLB
SCHEMBL1208272 0.85 ALDH1A1 (0.41) MAPTALDH1A1KMT2AMEN1POLB
SCHEMBL1209160 0.84 MAPT (0.47) MAPTALDH1A1KMT2AMEN1POLB
SCHEMBL1207334 0.83 MAPT (0.44) MAPTALDH1A1KMT2AMEN1POLB
SCHEMBL1208700 0.81 ALDH1A1 (0.45) MAPTALDH1A1KMT2AMEN1POLB
SCHEMBL1209503 0.81 MAPT (0.40) MAPTALDH1A1KMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES NYCOMED GMBH (DE) 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES BAX, BCL2, BAD MAPT 865/4885ALDH1A1 316/4885KMT2A 2064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.